Eco R1 Capital, LLC Aclaris Therapeutics, Inc. Transaction History

Eco R1 Capital, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$5.86 - $27.73 $8.85 Million - $41.9 Million	-1,509,812 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$2.65 - $7.61 $56,975 - $163,615	-21,500 Reduced 1.4%	1,509,812 $9.77 Million
Q2 2020 Aug 14, 2020	SELL	$1.04 - $1.73 $578,240 - $961,880	-556,000 Reduced 26.64%	1,531,312 $2.48 Million
Q4 2019 Feb 14, 2020	BUY	$1.02 - $1.97 $2.13 Million - $4.11 Million	2,087,312 New	2,087,312 $3.95 Million
Q1 2019 May 15, 2019	SELL	$5.63 - $7.84 $3.46 Million - $4.81 Million	-613,728 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$6.3 - $15.4 $3.87 Million - $9.45 Million	613,728 New	613,728 $4.54 Million
Q4 2017 Feb 14, 2018	SELL	$21.47 - $27.8 $1.29 Million - $1.67 Million	-60,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$23.02 - $28.8 $1.38 Million - $1.73 Million	60,000	60,000 $1.55 Million

52.4M

32.4K

3.3K

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $139M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

Get notified when there are updates to the investment portfolio of Eco R1 Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Eco R1 Capital, LLC with notifications on news.